The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | COVID-19 infection in patients with CLL
Antonio Cuneo, MD, St. Anna University Hospital, Ferrara, Italy, comments on the risk of developing severe COVID-19 infection in patients with chronic lymphocytic leukemia (CLL). Dr Cuneo explains that COVID-19 infection can lead to pneumonia, bacterial infection, and deterioration of the clinical status in patients with CLL, and it is therefore essential for these patients to be appropriately treated as early as possible. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
